ATG3 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.51332288314643E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.26449999979539E-07 |
Normal-vs-Stage2 |
1.847600E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.682200E-03 |
Stage1-vs-Stage2 |
3.904200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
7.400800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.639600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.92343968214482E-12 |
Normal-vs-AfricanAmerican |
3.936800E-01 |
Normal-vs-Asian |
1.149410E-01 |
Caucasian-vs-AfricanAmerican |
7.568800E-01 |
Caucasian-vs-Asian |
9.588200E-01 |
AfricanAmerican-vs-Asian |
6.661400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.92170000004699E-06 |
Normal-vs-Female |
1.2442999997031E-07 |
Male-vs-Female |
6.166400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.778200E-04 |
Normal-vs-Extreme_Weight |
1.81160000001235E-07 |
Normal-vs-Obese |
7.824000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
4.236000E-01 |
Normal_Weight-vs-Obese |
2.801200E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
5.149400E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.654200E-01 |
Normal-vs-Age(41-60Yrs) |
1.177560E-04 |
Normal-vs-Age(61-80Yrs) |
5.08590000114495E-08 |
Normal-vs-Age(81-100Yrs) |
7.688300E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.420800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.250810E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.443200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.214030E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.744200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.204200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
8.659200E-01 |
Normal-vs-Grade 3 |
5.767600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
3.679000E-01 |
Grade 2-vs-Grade 4 |
8.659200E-01 |
Grade 3-vs-Grade 4 |
5.767600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.41679956234509E-10 |
Normal-vs-N1 |
9.144900E-03 |
N0-vs-N1 |
3.235800E-01 |
|
|